Blue Sail Medical released its 2026 interim report, with net profit attributable to the parent company of 95.6789 million yuan. The company's total operating revenue was 3.705 billion yuan, and net cash inflow from operating activities was 421 million yuan. The latest asset-liability ratio was 38.50%, gross margin was 29.72%, ROE was 1.34%, and diluted earnings per share was 0.10 yuan. The company's total asset turnover ratio was 0.23 times, inventory turnover ratio was 2.35 times, the number of shareholders was 64,100, and the top ten shareholders held 362 million shares, accounting for 35.96% of the total share capital.
Blue Sail Medical Co LtdInterim report shows net profit of 95.6789 million yuan, but no comparative figures or market expectations provided, making impact unclear.